| 2003 |
NordMedica is founded by two senior executives with several years of international management experience from research based pharmaceutical companies, like Merck Sharpe and Dohme, Upjohn, Bayer and AstraZeneca |
| 2004 |
A short term distribution agreement for Denmark is signed with Austrian Ebewe Pharma regarding 5 cancer products, including the first generic version of paclitaxel |
| 2004 |
An exclusive distribution agreement for “a prepared system for multi organ preparation” is signed with Meddev, US for the five Nordic countries |
| 2005 |
An exclusive distribution agreement for Custodiol® is signed with Köhler Chemie, Germany for the five Nordic countries |
| 2005 |
6 proprietary products are acquired from Eli Lilly, US for Denmark and Iceland. Keflex®, Kefzol®, Nebcina®, Doloxene®, Vancocin® and Dobutrex® |
| 2005 |
A distribution agreement for Denmark is signed with Norwegian Farma Plus regarding 5 antibiotics |
| 2006 |
Vancocin® is acquired from Eli Lilly, US for the Swedish market |
| 2006 |
Neostigmin is acquired from Pfizer, US for the Swedish market |
| 2006 |
Distribution rights for a new formulation of Dobutrex® is acquired from Pharma Hameln regarding Denmark and Iceland |
| 2007 |
An exclusive distribution agreement is signed with Vianex, Greece for the Nordic countries |
| 2007 |
5 products are acquired from Pfizer for Sweden. Vibramycin®, Terramycin® with Polymyxin B, flurablastin, Adriamycin®, chloramphenicol succinat. Vibramycin®, Oral suspension is also acquired for Norway, Finland, the Netherlands, Belgium and Luxembourg |
| 2007 |
Pondocillin® is acquired for Denmark from Leo Pharma, Denmark |
| 2008 |
Amecrin® is acquired from Pfizer for Sweden, Germany, Switzerland, The Netherlands, Belgium and Luxembourg. Further rights for Amecrin in “compassionate use” for several international markets |
| 2008 |
Flurablastin and Adriamycin® is sold to Strides Arcolab and Vancocin® i.v. is divested to Farma Plus, Norway |
| 2008 |
Ampicillin is acquired for Denmark from Vepidan, Denmark |
| 2008 |
NordMedica SA is established as a principal subsidiary in Lugano, Switzerland. Managing Director for the company employed |
| 2009 |
Farma Plus establishes their own distribution in Denmark after 4 successful years of collaboration with NordMedica |
| 2009 |
NordMedica completed the acquisition of the product Estradurin® (polyestradiol) from Pfizer for 11 European countries |
| 2010 |
A Nordic product portfolio of 8 products - Ampicillin, Dobutrex®, Doloxene®, Keflex®, Kefzol®, Neostigmin®, Pondocillin®, and Vancocin® was divested to Pharmacodane ApS, a subsidiary of German STADA Arzneimittel AG |
